Most Popular Stories
- Debt payments still mire HCA
- Cleveland Clinic lists potential conflicts of interest online
- A new strategy for harried physicians: See patients in groups
- Forum: IT won't help much until practices shift operations
- Fitch changes not-for-profit hospital outlook to negative
- Rapid-response teams have little effect on cardiac arrest deaths
- Disruptive doctor behavior causes mistakes, intimidates workers
- AHA survey: Negative profit margins for hospitals
- DOD, VA move to SOA architecture to build interoperable systems
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Cleveland Clinic lists potential conflicts of interest online
- A new strategy for harried physicians: See patients in groups
Poll
Featured Jobs
-
California Internal Medicine
StaffPointe, LLC - near San Diego , CA -
Virginia Dialysis Registered Nurse
StaffPointe, LLC - north , VA -
Texas Manager of Respiratory Therapy
StaffPointe, LLC - Laredo , TX -
Texas NP or PA CEx1134
StaffPointe, LLC - Dallas , TX -
Florida Internist
StaffPointe, LLC - west , FL
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
SPOTLIGHT: Critics challenge direct-to-consumer TV ads for stent
May 15, 2008 — 6:59am ET
Over the last several months, consumers have been viewing a 60-second television ad for Johnson & Johnson's Cypher stent which, of course, plays up its potential benefits. Now, two critics of the ad have published an article in The New England Journal of Medicine arguing that the ad does far too little to warn consumers about the potential dangers of receiving a stent. The authors, Dr. William E. Boden of the State University of New York at Buffalo's medical school, and Dr. George Diamond of Cedars-Sinai Medical Center, question whether such high-risk procedures should be advertised directly to the public at all. Article
Be the first to comment
Related Stories
- Survey says: Hospitals not treating pain sufficiently
- Patients question hospital quality performance on key issues
- Study: Virtual colonoscopy effective at detecting polyps
- Study: Drugs may do as well as an angioplasty
- Study: Clot-sucking device cuts death rates for heart attacks
- Study: Social networks can have impact on health behavior
- Hospital night shifts severely lacking
- ALSO NOTED: Revenue growth slows for PA hospitals, but they remain profitable; JAMA rips journal use for off-label pharma marke
- FDA says Glaxo didn't report Avandia data
- SPOTLIGHT: NEJM issues correction over tobacco ties to cancer study
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





